# Page 1
To give administrative approval for procurement of essential anti-tuberculosis drugs under National Tuberculosis Elimination Programme through e-tendering for a period of two years by fixing the rates.
The Government of Maharashtra
the Department of Public Health
Government Resolution No: PRASHAMA-0919/ PR No.490/ HEALTH-7
10th Floor, Hospital Building
New Ministry, Mumbai- 400001.
The date: May 3, 2021.
Read: 1) Joint Director, Health Services (Leprosy and Tuberculosis), Pune vide letter No. Fixation of prices of medicines for two years for SAS/ Leprosy/ Cell AY/ NTEP/ Anti-Tuberculosis/ 550-554/2021 dated 04.01.2021.
Letter from Shri Manoj Jhalani, Additional Secretary& Mission Director, National Health Mission, New Delhi, dated 23.05.2019.
Letter dated 10.06.2019 from Dr. V.S. Salhotra, ADDG (TB), New Delhi.
4) Letter dated 13.10.2020 from Dr. Sanjay Kumar Mattoo, Joint Director (TB), Ministry of Health and Family Welfare (Central TB Division), New Delhi.
Consent note dated 28.12.2020 from the Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai.
6) Joint Director, Health Services (Leprosy and Tuberculosis), Pune vide letter No. Fixation of prices of medicines for two years for SAS/ Leprosy/ Cell AY/ NTEP/ Anti-Tuberculosis/ 21432/2021 dated 12.04.2021
The Proposal:
The government has set a target to eliminate TB from the country by 2025. The supply of anti-tuberculosis drugs to the State is done through the Central Tuberculosis Department, New Delhi, Government of India. However, at times, if there is a delay in the procurement process of anti-TB drugs at the central level or if the supply of these drugs is delayed due to some other technical difficulties, the Central TB Department may issue a letter to the State or Central TB Commission.
# Page 2
Government Resolution No: PRASHAMA-0919/ PR No.490/ HEALTH-7
Procurement of certain anti-tuberculosis drugs allowed at the local level at the district level
is given. Accordingly, the drugs are procured at the state level through Haffkine Biopharma Corporation, Mumbai or all district/ city TB officers are allowed to procure the drugs locally as per their requirement.
However, it is because anti-tuberculosis drugs cost less at the local level.
They are not available on time and are in short supply. Also, the prices of these medicines vary from district to district. This can be challenged in an audit. Therefore, the District/ City TB Officer informs about the non-availability of these drugs at the local level. As a result, the appropriate dose for tuberculosis patients
And there are barriers to treatment. Patients should be given this medicine for the prescribed period of time without interruption, in the right dose and without interruption. If they don't their disease
Tuberculosis can also cause death, and people with the disease can become infected.
The Central Government has also recommended to all the States to establish a tariff agreement vide their letters dated 23.05.2019 and 13.10.2020. (All States to establish rate contracts of all drugs and diagnostics items under NTEP, except for the CBNAAT/ TruNAT machines and cartridges/ chips to the extent of 25% of the annual requirements at the beginning of each financial year. )
Read the above. Joint Director, Health Services (Leprosy and
Under the National Tuberculosis Elimination Programme (NTEP) launched by the National Institute of Tuberculosis (NITP), Pune, e-tendering of essential anti-tuberculosis drugs (25% of the annual requirement) for two years and procurement of anti-tuberculosis drugs.
The matter of administrative approval of the proposal to revise the rate contract, as required, was under consideration of the government.
Government's decision:
The facts mentioned in the preceding paragraph and the urgent need for TB patients to receive medication in the right dosage and in an uninterrupted manner during the current Corona pandemic
25% of the total annual requirement.
Essential anti-TB drugs through Haffkine Biopharma Corporation, Mumbai
Page 2 of 6
# Page 3
Government Resolution No: PRASHAMA-0919/ PR No.490/ HEALTH-7
The following is the rate contract for two years:
Administrative approval is granted subject to conditions. The details are as follows
It is:
List of Anti-Tuberculosis Drugs to be Rated and Required
--------------------------------------------------------------------------------------------------------------------------------------------------------------------
| Sr. No | Name of anti TB Drugs                      | Unit of measurement      | Required Quantity (25% of Yearly requirement) | Approximate Price | Total Rs.   |
| 1      | Moxifloxacin 400mg                         | Tablet                   | 1240583                                       | 15.67             | 19439935.61 |
| 2      | Ethlonamide 125mg                          | Tablet                   | 11248                                         | 5.04              | 56689.92    |
| 3      | Ethlonamide 250mg                          | Tablet                   | 367985                                        | 5.82              | 2141672.70  |
| 4      | Clofazimin 50mg                            | Capsule                  | 72421                                         | 1.09              | 78938.89    |
| 5      | Clofazimin 100mg                           | Capsule                  | 1010071                                       | 1.69              | 1707019.99  |
| 6      | Pyrazinamide 500mg                         | Tablet                   | 511767                                        | 1.29              | 660179.43   |
| 7      | Pyrazinamide 750mg                         | Tablet                   | 376071                                        | 1.56              | 586670.76   |
| 8      | Ethambutol 400mg                           | Tablet                   | 124625                                        | 1.71              | 213108.75   |
| 9      | Ethambutol 800mg Tab                       | Tablet                   | 336051                                        | 3.03              | 1018234.53  |
| 10     | Isonlazid 300mg Tab                        | Tablet                   | 6026354                                       | 0.94              | 5664772.76  |
| 11     | Bedaqulline 100mg                          | Jar (jar of 188 Tablets) | 1392                                          | 26000             | 361920000   |
| 12     | Delamanid 150mg                            | Tablet                   | 34860                                         | 172.09            | 5999057.40  |
| 13     | Levofloxacin 250mg                         | Tablet                   | 395622                                        | 1.46              | 577608.12   |
| 14     | Levofloxacin 500mg                         | Tablet                   | 745934                                        | 2.48              | 1849916.32  |
| 15     | Cycloserine 250mg                          | Capsule                  | 1864545                                       | 17.15             | 31976946.75 |
| 16     | Linezolide 600mg                           | Tablet                   | 1418382                                       | 34.68             | 49189487.76 |
| 17     | Pyridoxin 100mg Tab                        | Tablet                   | 504599                                        | 1.78              | 898186.22   |
| 18     | Sodium-PAS-04 GM. Sachet (9.2gm with 60BA) | Sachet                   | 198000                                        | 50.98             | 10094040    |
| 19     | Amikacin 500mg                             | Ampoule                  | 24381                                         | 44.85             | 1093487.85  |
| 20     | Rifampicin 150mg                           | Capsule                  | 52290                                         | 2.47              | 129156.30   |
| 21     | Rifampicin 450mg                           | Capsule                  | 97259                                         | 4.91              | 477541.69   |
| 22     | 4 FDCs (Adult)                             | Strip of 28 Tablets      | 232275                                        | 130.38            | 30284014.50 |
| 23     | 3 FDCs (Adult)                             | Strip of 28 Tablets      | 464553                                        | 105.10            | 48824520.30 |
| 24     | 3 FDCs (Pediatric)                         | Strip of 28 Tablets      | 33360                                         | 91.72             | 3059779.20  |
| 25     | 2 FDCs (Pediatric)                         | Strip of 28 Tablets      | 66726                                         | 76.38             | 5096531.88  |
| 26     | Ethambutol 100mg                           | Tablet                   | 2802387                                       | 0.75              | 2101790.25  |
| 27     | Isoniazid 100mg                            | Tablet                   | 1007100                                       | 0.53              | 533763      |
| 28     | Pyridoxin 25mg                             | Tablet                   | 675000                                        | 0.75              | 506250      |
| 29     | Pyridoxin 50mg                             | Tablet                   | 5535000                                       | 1.05              | 5811750     |
| Total  | 266263050.90                               |
--------------------------------------------------------------------------------------------------------------------------------------------------------------------
Page 3 of 6
# Page 4
Government Resolution No: PRASHAMA-0919/ PR No.490/ HEALTH-7
Administrative approval is subject to the following terms and conditions. (1) The demand for drugs should be determined on the basis of the number of TB patients on treatment in 2019-20 and the number of patients and the number of drugs required (including doses) and the duration of delivery of drugs to the supplier should be strictly matched.
Ministry of Health and Family Welfare, Government of India, New Delhi (Central TB Division) dated 23.05.2019 and dt. Action should be taken as per the guidelines issued vide letter dated 13.10.2020. The requirement/ demand of TB drugs should be assessed and purchased accordingly.
These drugs should be procured only as per the instructions of the Central Tuberculosis Organisation, New Delhi and in case of insufficient supply from them.
4) The supply of these medicines will be mandatory as per the demand made by the district and at the district level.
5) It should be ensured that the specifications of these medicines are as prescribed and updated by the Central Government. The technical specifications of the items to be procured should be prepared by the concerned experts (technical committee/ officials) as per the guidelines approved by the Central Government. After that, you have to buy them.
The procurement process should be carried out within the prescribed limits as per the provisions of the revised rule book of procedures for office procurement to be carried out by government departments published under the Government Decision, Industry, Energy and Labour Department, No. 2014/ PR No. 82/ Part-II/ Industry-4, dated December 1, 2016.
7) Pre/ post dispatch random sample inspection of the items to be procured should be done to ensure that only the items with proper and correct specifications are purchased.
8) Storage and distribution of the items to be procured after supply as well as supply chain management Page 4 of 6
# Page 5
Government Resolution No: PRASHAMA-0919/ PR No.490/ HEALTH-7
And inventory management should be done in a proper manner to ensure that these items do not go unused and they are used in a timely manner.
The cost for the proposed procurement of these drugs should be met from the subsidy available under the NCDP Flexipool/ Free Diagnostics and Free Drugs/ National Free Diagnostic Services-Free Pathological Services (FMR Code 6.4.1) and Procurement of Drugs under National Tuberculosis Elimination Programme (FMR Code- 6.2.14.2).
10) Also, it should be ensured that there is no duplication in the purchase of these items.
The entire responsibility of this will be of the director.
The guidelines of the Central Vigilance Commission (CVC) should be strictly followed while carrying out the entire procurement process.
30/ Part- 2/2013/ Regulations, dated 17.04.2015 read with Annexure A No.4 of the Financial Powers Rules, 1978, Part I, Sub-Section-II, Rule No. 7 in front of No. 6 conditions must be met.
13) Supply orders should be issued only after the approval of the Purchasing Committee after the completion of the procurement process. In this regard, the Public Health Department, vide Government Resolution No. buy
Action to be taken as per the provisions of the Government Resolution 2016/ EC 240/ Health-8 dated 26.07.2017.
The Programme Heads shall ensure that the proposed procurement does not exceed 25% of the annual demand as notified under ASHAAP-T- 18018/04/2018-Part (2) dated 23.05.2019 of the Additional Secretary and Mission Director (NHM), Government of India, Ministry of Health& Family Welfare, New Delhi.
The Commissioner (Health Services) and Mission Director, National Health Mission, Mumbai, Director is fully responsible for ensuring that the conditions mentioned in the above 1 to 14 are fulfilled and the procurement of medicines is done as per rules and requirements.
Page 6 of 5
# Page 6
Government Resolution No: PRASHAMA-0919/ PR No.490/ HEALTH-7
(Health Services), Commissionerate of Health Services, Mumbai, Joint Director, Health Services (Leprosy and Tuberculosis), Pune and Programme Head.